Poolbeg Pharma PLC (POLB)의 가격은 얼마입니까?

Poolbeg Pharma PLC (POLB)의 가격은 $0.11565963입니다.

Poolbeg Pharma PLC (POLB)의 시가 총액은 무엇입니까?

Poolbeg Pharma PLC (POLB)의 시가 총액은 $882.99K입니다.

Poolbeg Pharma PLC (POLB) 발행주식수

Poolbeg Pharma plc is a clinical-stage biopharmaceutical company based in the United Kingdom, focused on developing treatments for infectious diseases. Its pipeline features several key programs: POLB 001, a p38 MAP Kinase inhibitor intended for severe influenza; POLB 002, a pioneering, in-licensed RNA-based immunotherapy administered intranasally to combat respiratory virus infections; and POLB 003, an intramuscular vaccine aimed at preventing Melioidosis. Beyond specific therapeutic candidates, Poolbeg also holds licensed access to advanced micro- and nanoencapsulation technology for an oral vaccine delivery system designed to stimulate gut immunity. The company further advances its research through an artificial intelligence-powered drug program. Additionally, Poolbeg is developing a biomarker platform to identify individuals at high risk of severe disease, alongside a model-derived vaccine discovery platform to pinpoint novel vaccine candidates. Incorporated in 2021, Poolbeg Pharma plc is headquartered in London.

연도	발행 주식 수	변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.

연도

발행 주식 수

변화

제공된 날짜에 대한 데이터가 충분하지 않습니다.

회사	발행 주식 수	차이	국가
Vertex Pharmaceuticals Incorporated VRTX.US	253.90M	-	US
Argenx SE ARGX.US	62.19M	-	NL
Lonza Group AG LONN.SW	-	-	CH
Samsung Biologics Co.,Ltd. 207940.KS	-	-	KR
UCB S.A. UCB.BR	0.00	-	BE

회사

발행 주식 수

차이

국가